Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer

Ovarian cancer survival remains poor despite recent advances in our understanding of genetic profiles. Unfortunately, the majority of ovarian cancer patients have recurrent disease after chemotherapy and lack other treatment options. Wnt signalling has been extensively implicated in cancer progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Henry, C E, Llamosas, E, Djordjevic, A, Hacker, N F, Ford, C E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945749/
https://www.ncbi.nlm.nih.gov/pubmed/27239958
http://dx.doi.org/10.1038/oncsis.2016.32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945749/
https://www.ncbi.nlm.nih.gov/pubmed/27239958
http://dx.doi.org/10.1038/oncsis.2016.32

Ejemplares similares